Becton, Dickinson and Company
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Becton, Dickinson and Company's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $35 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 91% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 34% of its market value (net debt). Lower than 89% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Sep 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$210Over the last 3 years, every $100 of reported profit came with $210 of operating cash.
Higher than 79% of Healthcare companies in United States.
Self-Funding Ratio
4.3×Over the last 3 years its own operating cash covered its investment spending (capex) 4.3 times.
Higher than 84% of Healthcare companies in United States.
Cash Locked Ratio
$21For every $100 of sales, $21 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $19 tied up three years earlier.
Less money tied up than 55% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$3Sales grew 16% in 3 years, but profit fell: $3 less profit per $100 of extra sales.
Lower than 71% of Healthcare companies in United States.
Asset Productivity Ratio
+16% / +5%In 3 years sales changed by +16% while total assets changed by +5%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
2.2×Debt due within a year is covered 2.2 times by its yearly operating cash.
Higher than 74% of Healthcare companies in United States.
Cash Cushion Ratio
−34%Debt, after subtracting cash, equals 34% of its market value (net debt).
Lower than 89% of Healthcare companies in United States.
Tangible Assets Ratio
35%Of every $100 the company owns, $35 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 91% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 85% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Becton, Dickinson and Company owes $0.52 for every $1 it owns. Net profit fell 2% in the year to Sep 2025, and shrank 2% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Sep 2025.
P/E ratio
46.6Investors pay $46.6 for every $1 of Becton, Dickinson and Company's yearly profit, higher than 79% of Healthcare companies in United States.
P/B ratio
2.24The share price is 2.24 times Becton, Dickinson and Company's book value per share, lower than 54% of Healthcare companies in United States.
Market cap
$54.6 BThe total market value of all of Becton, Dickinson and Company's shares at today's price (share price × number of shares), larger than 97% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$24.4 BWhat Becton, Dickinson and Company would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$89.64Net worth divided by the number of shares. The share price of $200.42 is 2.2 times this, which is the P/B above.
Return on equity (ROE)
6.6%Becton, Dickinson and Company earned 6.6% on its shareholders' money over the last year, higher than 81% of Healthcare companies in United States.
Owes vs Owns
0.52×Becton, Dickinson and Company owes $0.52 for every $1 it owns (moderate), higher than 57% of Healthcare companies in United States.
Dividend yield
2.16%Becton, Dickinson and Company pays 2.16% of its share price as dividends a year, higher than 76% of dividend-paying Healthcare companies in United States.
Revenue growth
+8%Revenue rose 8% in the year to Sep 2025, and grew 5% a year on average over 3 years.
Profit growth
-2%Net profit fell 2% in the year to Sep 2025, and shrank 2% a year on average over 3 years.
Profit margin
7.7%Becton, Dickinson and Company keeps $8 of every $100 of revenue as net profit.
Cash quality
2.0×Cash from Becton, Dickinson and Company's business was 2.0× its reported profit in the year to Sep 2025 — its profit turned into cash.
Interest cover
4.9×Becton, Dickinson and Company's operating profit covered its interest costs 4.9 times in the year to Sep 2025.
Cash vs debt
Net debtBecton, Dickinson and Company had $18.5 B more debt than cash (net debt) at Sep 2025.
Questions
What is Becton, Dickinson and Company's P/E ratio?
Investors pay $46.6 for every $1 of Becton, Dickinson and Company's yearly profit, higher than 79% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Becton, Dickinson and Company: $54.6 B ÷ $24.4 B (30 Jun 2026) = 2.2.
What is Becton, Dickinson and Company's return on equity?
Becton, Dickinson and Company earned 6.6% on its shareholders' money over the last year, higher than 81% of Healthcare companies in United States.
How much does Becton, Dickinson and Company owe compared with what it owns?
Becton, Dickinson and Company owes $0.52 for every $1 it owns (moderate), higher than 57% of Healthcare companies in United States.
Does Becton, Dickinson and Company pay a dividend?
Yes. Becton, Dickinson and Company pays 2.16% of its share price as dividends a year, higher than 76% of dividend-paying Healthcare companies in United States.
Is Becton, Dickinson and Company's revenue growing?
Revenue rose 8% in the year to Sep 2025, and grew 5% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.